Multiple Myeloma (MM) cancer has been and continues to be the subject of many research studies. The main goal is to improve the therapeutic/treatment process of the survival ... data-driven statistical model for the…
initiated. With the constellation of renal insufficiency stage III along with macrocytic anemia, multiple myeloma was suspected by the medicine team. Serum protein electrophoresis showed M protein ... latest calcium…
many studies have been carried out on monoclonal gammopathy of unknown significances (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM), their classification and underlying pathogenesis are far from…
Backround: Multiple myeloma (MM) and the associated immunomodulatory (IMiD)treatments are associated with risk of vascular complications. Thrombin generation (TG) assessment reflects the equilibrium between procoagulant…
Background: Risk stratification in Multiple Myeloma is typically done based on a set of chromosomal abnormalities including translocations and deletions and karyotype abnormalities such as hypodiploidy and…
objective of this study was to estimate the global incidence and prevalence of multiple myeloma by region over the next 10 years using a multi-factorial forecast model. Methods: Using ... critically appraised set of…
play an important role in epigenetic regulation, which could be involved in pathogenesis of multiple myeloma (MM). Active DNA demethylation occurs during 5-methylcytosine through TET (Ten Eleven Translocation) enzyme…
Abstract: Background and objectives: Multiple myeloma is a complex neoplastic plasma cell disorder which necessitates a high index of suspicion and a rational approach to diagnosis. The diagnosis requires meeting…
Plasmacytoma (plasma cell neoplasm) presented as multiple myeloma, solitary plasmacytoma of bone (SBP) and extramedullary plasmacytoma (EMP). Types of plasmacytoma vary from one another in terms of clinical findings…
Introduction: Multiple myeloma is the most common bone malignancy characterized by malignant proliferation of plasma cells leading to production of a monoclonal paraprotein. Varied clinical presentations are noted…
certain human cancers. However, the expression levels and functional importance of PSMC2 in multiple myeloma are still uncertain. PSMC2 expression in the levels of mRNA and protein was detected ... western blot assay…
Introduction: Multiple myeloma is a neoplastic disorder characterized by proliferation of a single clone of plasma cells leading to varied clinical presentations. Various clinical and laboratory parameters have been…
nodule that frequently develops on the tongue. Moreover amyloidosis is often accompanied by multiple myeloma. Herein, we reported a case of multiple myeloma diagnosed from tongue amyloidosis. Case presentation…
conducted to figure out the long-term effectiveness of bortezomib in managing patients with multiple myeloma. To retrieve relevant literature, the Chinese National Knowledge Infrastructure and Wanfang databases were…
sent. The finding of lytic punched out lesions in the skull X ray suggested multiple myeloma. Multiple Myeloma represents pathology of diverse distribution. Although, the incidence is not reported
Multiple myeloma treatment has evolved over the past two decades. The introduction of novel agents has significantly improved overall survival. With marked improvement in survival rates, the development of second…
cells and heart muscle. Bortezomib has recommended as novel approach to the treatment of multiple myeloma producing rapid control. AIM: The aim of this study was to investigate the relationship ... serum Aspartate Amino…
Background: Multiple myelomas (MM) is one of the commonest hematological malignancies of public health importance in low-income countries of sub-Saharan Africa. It accounts for 1% of all cancer ... lymphoma. MM accounts…
first two monoclonal antibodies in the treatment of patients with relapsed and refractory multiple myeloma was a watershed moment for the multiple myeloma community in 2015. Despite early setbacks, monoclonal…
describe the epidemiological, clinical, biological, histological, treatment and outcome of renal damage in the Multiple myeloma, identify predictors of poor renal response in the Multiple myeloma and mortality of…
Multiple Myeloma (MM) has been and continues to be the subject of many research studies. The main goal is to improve the therapeutic/treatment process of survival of MM patients ... data-driven statistical model for the…
Advances in medical management of multiple myeloma have improved the potential for lesional bone healing, decreasing numbers of skeletal related events and need for radical surgical intervention. However, documented…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.